Treatment of Acute Stroke With Cromolyn(Single Dose)

Overview

Mastocytes were proven to have a central rule in their development of the lipoid plaque of the vascular system. Mastocytes also has an important role in the stabilisation of the plaque in the building of the brain barrier. Different animal studies show that the inhibition of the mastocyte activity decreases significantly the risk of secondary bleeding post ischaemic stroke.It was also shown that post stroke inflammation process was also blocked by the inhibition of mastocytes.Other studies showed up to 100% decrease in the brain barrier disruption and post stroke oedema, after treatment with mastocyte inhibitors. Cromolyn is a synthetic drug which has an anti-allergic effect by inhibition of the mastocytes. This drug is a well known,safe drug and is the main sub-substance that was used in the previously mentioned studies.

Study Type

  • Study Type: Interventional
  • Study Design
    • Intervention Model: Parallel Assignment

Interventions

  • Drug: CROMOLYN
    • Cromolyn 200mg (dissolved in water) given 4 times a day
  • Drug: sugar pill
    • sugar pill Dissolved in water taken 4 times daily 30 minutes prior to meals

Arms, Groups and Cohorts

  • Placebo Comparator: sugar pill
    • sugar pill dissolved in water to be given 4 times a day 30 minutes prior to meals
  • Active Comparator: Cromolyn
    • Cromolyn dose of 200mg(dissolved in water) will be given 4 times a day(30 minutes before a meal)

Participating in This Clinical Trial

Inclusion Criteria

1. Infarction of the anterior Circulation system. 2. Both genders 3. Age > 20 years 4. NIHSS > 5 - Exclusion Criteria:

1. Non- ischaemic stroke 2. Additional disease of the CNS 3. Known allergy to cromolyn 4. Diseae of mastocytosis 5. Renal or Hepatic failure (acute or chronic) 6. Inability to sign consent form (dementia or sensory aphasia) 7. Lacunar infarctions 8. INfarction present in cerebellum or brain stem -

Gender Eligibility: All

Minimum Age: 20 Years

Maximum Age: 90 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Wolfson Medical Center
  • Overall Official(s)
    • Yair Lampl, Neurologist, Principal Investigator, Wolfson Medical Center
  • Overall Contact(s)
    • Yair Lampl, Neurologist, =972-3-5028512, y_lampl@hotmail.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.